Tuesday, July 15, 2025
spot_img

DGCI panel approve Covovax EUA for 7-11 age group: Source

Date:

Share post:

spot_imgspot_img

New Delhi, June 25:  Drugs Controller General of (DCGI) India on Friday recommended Emergency Use Authorisation (EUA) for Serum Institute of India’s Covovax vaccine for children aged 7-11, a source on Friday.

“The Subject Expert Committee of Drugs Controller General Of India has recommended Serum Institute of India’s (SII) vaccine Covovax for children in the age group of 7-11 years,” said the source.

The expert panel recommendation has been sent to the DCGI for final approval.

However, DGCI will review the recommendation before nodding for final approval. The expert panel in its last meeting in April had sought more information from Serum Institute over the application, as per the source.

India’s drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, and in the 12-17 age group with certain conditions on March 9.

IANS

spot_imgspot_img

Related articles

BSF apprehends smuggler along Indo-Bangla border; seizes silver ornaments worth Rs 16.49 lakh

Kolkata, July 14: The Border Security Force (BSF) has apprehended a smuggler and seized 16.71 kg silver ornaments...

Lok Sabha ushers in AI era; adopts multilingual access, digital attendance, real-time transcriptions

New Delhi, July 14: In a landmark move to modernise parliamentary operations, the Lok Sabha Secretariat has unveiled...

3rd Test: Resilient Jadeja brings up 4th successive fifty, drags match into final session

London, July 14: A resilient Ravindra Jadeja brought up his fourth successive half-century in Tests and dragged the...

Centre to issue new guidelines to promote first-time exporters: Piyush Goyal

New Delhi, July 14: The government would soon come out with more guidelines on how new markets, new...